Market Closed -
Nasdaq
04:00:00 2024-05-15 pm EDT
5-day change
1st Jan Change
21.66
USD
+2.70%
+12.64%
+76.53%
This article is reserved for members
Not a member ?
Free registration
Transcript : Silk Road Medical, Inc, Q1 2024 Earnings Call, Apr 30, 2024
Apr. 30
Earnings Flash (SILK) SILK ROAD MEDICAL Reports Q1 Revenue $48.5M, vs. Street Est of $44.7M
Apr. 30
MT
Silk Road Medical, Inc Provides Revenue Guidance for the Full Year 2024
Apr. 30
CI
Silk Road Medical, Inc Reports Earnings Results for the First Quarter Ended March 31, 2024
Apr. 30
CI
Silk Road Medical Strengthens TCAR Portfolio with Launch of ENROUTE Transcarotid Neuro Protection System Plus
Apr. 02
CI
North American Morning Briefing : Stock Futures -2-
Mar. 08
DJ
Silk Road Medical Inc. and Genesis MedTech Group have signed an exclusive distribution agreement to introduce the TCAR® core products
Mar. 07
CI
Argus Upgrades Silk Road Medical to Buy From Hold, Price Target is $24
Mar. 07
MT
Silk Road Medical Expands TCAR Portfolio with Launch of Tapered Enroute®? Transcarotid Stent System
Mar. 05
CI
Piper Sandler Raises Price Target on Silk Road Medical to $18 From $11, Maintains Neutral Rating
Feb. 29
MT
Transcript : Silk Road Medical, Inc, Q4 2023 Earnings Call, Feb 28, 2024
Feb. 28
Earnings Flash (SILK) SILK ROAD MEDICAL Reports Q4 Revenue $47.3M, vs. Street Est of $42M
Feb. 28
MT
Silk Road Medical, Inc Provides Revenue Guidance for the Full Year 2024
Feb. 28
CI
Silk Road Medical, Inc Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023
Feb. 28
CI
North American Morning Briefing : S&P 500 Seen -2-
Jan. 22
DJ
Sector Update: Health Care Stocks Steady Late Afternoon
Jan. 19
MT
Silk Road Medical Shares Rise After Upgrade From Stifel
Jan. 19
MT
Stifel Upgrades Silk Road Medical to Buy From Hold, Raises Price Target to $20 From $9
Jan. 19
MT
Transcript : Silk Road Medical, Inc Presents at J.P. Morgan 42nd Annual Healthcare Conference 2024, Jan-10-2024 01:30 PM
Jan. 10
Lake Street Initiates Silk Road Medical at Buy Rating With $20 Price Target
Jan. 03
MT
Oppenheimer Adjusts Silk Road Medical Price Target to $25 From $30, Maintains Outperform Rating
Nov. 09
MT
Transcript : Silk Road Medical, Inc, Q3 2023 Earnings Call, Nov 08, 2023
Nov. 08
Earnings Flash (SILK) SILK ROAD MEDICAL Reports Q3 Revenue $44.4M, vs. Street Est of $44.3M
Nov. 08
MT
Silk Road Medical, Inc Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
Nov. 08
CI
Silk Road Medical, Inc Provides Revenue Guidance for the Full Year 2023
Nov. 08
CI
Duration Auto. 2 months 3 months 6 months 9 months 1 year 2 years 5 years 10 years Max.
Period Day Week
More charts
Silk Road Medical, Inc. is a medical device company that is focused on reducing the risk of stroke and its impact. The Company has developed an approach for the treatment of carotid artery disease called TransCarotid Artery Revascularization (TCAR). TCAR is a clinically proven procedure combining surgical principles of neuroprotection with minimally invasive endovascular techniques to treat blockages in the carotid artery at risk of causing a stroke. Its product portfolio consists of five single-use components: ENROUTE Transcarotid Neuroprotection System, ENROUTE Transcarotid Stent System, ENHANCE Transcarotid Peripheral Access Kit, ENROUTE 0.014'' Guidewire and ENROUTE Enflate Transcarotid RX Balloon Dilation Catheter. It manufactures ENROUTE NPS and ENROUTE NPS PLUS, or its ENROUTE NPS products, at its facilities in Sunnyvale, California and Plymouth, Minnesota. These facilities provide an aggregate of over 35,000 square feet of space for its production and distribution operations.
More about the company
Last Close Price
21.66
USD
Average target price
19
USD
Spread / Average Target
-12.28%
Consensus
+951% of historical performance
More than 20 years at your side
Our Experts are here for you
OUR EXPERTS ARE HERE FOR YOU
Monday - Friday 9am-12pm / 2pm-6pm GMT + 1
marketscreener.com**derivatives**en**/dynamic-chart/**Premium**Expert**Access**Annual**Monthly**
-40% Limited Time Offer : Our subscriptions help you unlock hidden opportunities.**#000000**/services/solutions/**#fff826**#ff3000**#ffffff**
BENEFIT NOW **0**linear-gradient(180deg, rgba(42,73,76,1) 0%, rgba(28,30,51,1) 53%);**linear-gradient(180deg, rgba(255, 248, 38,1) 0%, rgba(247, 239,1) 53%);**date_fin_hors_prolongation**49**on all our subscriptions**
#252525**/registration/member/**Blanc**1**7**To continue browsing, please register!**#ffffff50**14px**#33d251**